JIPYONG LLC

Facilitating Access to Korean Capital Markets: Lifting the Foreign Investor Registration Policy and Mandating English Disclosures

JIPYONG’s 2022 Year in Review

Korea Includes Nuclear Power in the Revised K-Taxonomy

Jipyong represents the Commissioner of Busan Regional Food and Drug Administration in the Case of Revocation of the Corrective Order for Krill Oil Products and Obtains Remand after Reversal/ Quashing from the Supreme Court

Private Equity Funds in Korea’s M&A Market